Total Visits

Views
A personalized medicine ex vivo test to predict clinical response to first line induction therapy with idarubicin and cytarabine in patients with acute myeloid leukemia10

Select a period of time:

Views

Views
May 20241
June 20244
July 20241
August 20240
September 20240
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
 

Top cities views

Views
Fort Worth1
Gallatin1